2020
DOI: 10.1016/j.ymgme.2019.11.419
|View full text |Cite
|
Sign up to set email alerts
|

Lyso-Gb3: A valid follow-up marker of treatment in male Fabry disease patients?

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles